05
Jun
India has ordered 300 million doses of an unnamed amd unapproved vaccine from Indian firm Biological E. The coronavirus vaccine is is in Phase 3 trials, and had showed "promising results" in the first two phases, the federal government said in a statement. However, the $206m order has not received emergency approval. India has administered just over 220 million jabs so far, although much of its 1.4 billion population is now eligible for the vaccine. Less than 15% of the country has received at least one dose of the vaccination, largely because of a severe shortage of doses. India is…
